Industries, particularly high tech, may be waiting for the U.S. Supreme Court decision, expected this coming spring, in the Bilski case to decide some fundamental questions of when you can patent ...
A unanimous U.S. Supreme Court ruling Monday backed away from a decades-old legal test that high-tech firms argue has sparked an abundance of obvious patents. In a hotly anticipated decision that ...
Business method patents have been a contentious issue, with some saying that they're necessary for software innovation and others claiming that they prevent innovation. The Bilski case, which will be ...
“[O]ur elimination of the rigid Rosen-Durling test is compelled by both the statute and Supreme Court precedent.” – CAFC opinion But in June 2023, the court granted an increasingly rare en banc review ...
A new method for evaluating hearing has received a second patent by the U.S. Patent and Trademark Office. Work leading to the patent, “Method for Determining Hearing Thresholds in the Absence of ...
An American firm’s new European patent on a screening test for a genetic mutation that causes breast cancer has created an uproar among geneticists in Israel and Europe, who say the patent raises ...
Purpose: Fragmented ownership of diagnostic gene patents has the potential to create an “anticommons” in the area of genomic diagnostics, making it difficult and expensive to assemble the patent ...
A new method for evaluating hearing has received a second patent by the U.S. Patent and Trademark Office. Work leading to the patent, “Method for Determining Hearing Thresholds in the Absence of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback